Pediatr Gastroenterol Hepatol Nutr.  2015 Jun;18(2):108-114. 10.5223/pghn.2015.18.2.108.

Abdominal Subcutaneous Fat Thickness Measured by Ultrasonography Correlates with Hyperlipidemia and Steatohepatitis in Obese Children

Affiliations
  • 1Department of Pediatrics, Gachon University Gil Medical Center, Incheon, Korea. onecar@gilhospital.com
  • 2Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • 3Department of Nursing, Gachon University, Incheon, Korea.

Abstract

PURPOSE
The aim of this study is to evaluate the relationship between abdominal subcutaneous fat thickness measured by ultrasonography (US) and serum lipid profile and liver transaminases in obese children.
METHODS
One hundred and sixty-six children diagnosed with obesity from May 2001 to December 2013 were included in this study. Data on serum lipid profile and liver transaminases were collected from clinical records. Abdominal subcutaneous fat thickness and grade of hepatic steatosis were evaluated by US.
RESULTS
Of the 166 children, 107 were diagnosed with hepatic steatosis by US, 46 with grade I, 56 with grade II, and five children with grade III. According to the grade of hepatic steasosis, the average values of midline abdominal subcutaneous fat thickness and right flank abdominal subcutaneous fat thickness measured 2.9+/-0.8 cm and 1.9+/-0.7 cm in the normal group, 3.3+/-0.8 cm and 2.0+/-0.7 cm in grade I, 3.8+/-0.8 cm and 2.3+/-0.8 cm in grade II, and 4.1+/-0.8 cm and 2.8+/-1.4 cm in grade III, respectively. Abdominal subcutaneous fat thickness correlated with grade of hepatic steatosis (p<0.01). In addition, abdominal subcutaneous fat thickness correlated with concentration of serum lipids and liver transaminases in the age group of 12-14 years (p<0.01).
CONCLUSION
Abdominal subcutaneous fat thickness measured by US can be used as a reliable predictor of possible hyperlipidemia and steatohepatitis in children, especially during the adolescent stage.

Keyword

Child; Obesity; Ultrasonography; Abdominal subcutaneous fat; Hyperlipidemias; Steatohepatitis; Fatty liver

MeSH Terms

Adolescent
Child*
Fatty Liver*
Humans
Hyperlipidemias*
Liver
Obesity
Subcutaneous Fat, Abdominal*
Transaminases
Ultrasonography*
Transaminases

Figure

  • Fig. 1 Abdominal subcutaneous fat on ultrasonography image. (A) Midline abdominal subcutaneous fat thickness (about 3.9 cm) was measured transversely at the one centimeter caudal to the umbilicus level. (B) Right flank abdominal subcutaneous fat thickness (about 1.9 cm) was measured coronally at two locations of the right flank, and the average value was recorded. The image was captured when the transducer just had contact with the skin to avoid compressing the subcutaneous adipose fascia.

  • Fig. 2 Analysis of variance between grade of hepatic steatosis and midline abdominal subcutaneous fat thickness (MASFT), *p<0.01.

  • Fig. 3 Analysis of variance between grade of hepatic steatosis and right flank abdominal subcutaneous fat thickness (RFASFT), *p<0.01.


Reference

1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization;2011. p. 22–31.
2. Lobstein T, Baur L, Uauy R. IASO International Obesity TaskForce. Obesity in children and young people: a crisis in public health. Obes Rev. 2004; 5:Suppl 1. 4–104.
Article
3. Pulgaron ER, Delamater AM. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diab Rep. 2014; 14:508.
Article
4. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011; 365:1876–1885.
Article
5. Riazi A, Shakoor S, Dundas I, Eiser C, McKenzie SA. Health-related quality of life in a clinical sample of obese children and adolescents. Health Qual Life Outcomes. 2010; 8:134.
Article
6. Kim HS, Park J, Ma Y, Ham OK. Factors influencing health-related quality of life of overweight and obese children in South Korea. J Sch Nurs. 2013; 29:361–369.
Article
7. Lee HH, Choi SK, Seo JS. Obesity index and related factors among elementary school students visiting pediatric department of general hospital. J Korean Diet Assoc. 2012; 18:186–199.
Article
8. Mathur P, Das MK, Arora NK. Non-alcoholic fatty liver disease and childhood obesity. Indian J Pediatr. 2007; 74:401–407.
Article
9. Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J. 2005; 52:519–524.
Article
10. Rothney MP, Catapano AL, Xia J, Wacker WK, Tidone C, Grigore L, et al. Abdominal visceral fat measurement using dual-energy X-ray: association with cardiometabolic risk factors. Obesity (Silver Spring). 2013; 21:1798–1802.
Article
11. Schlecht I, Wiggermann P, Behrens G, Fischer B, Koch M, Freese J, et al. Reproducibility and validity of ultrasound for the measurement of visceral and subcutaneous adipose tissues. Metabolism. 2014; 63:1512–1519.
Article
12. Wagner DR. Ultrasound as a tool to assess body fat. J Obes. 2013; 2013:280713.
Article
13. Fishbein MH, Mogren C, Gleason T, Stevens WR. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2006; 42:83–88.
14. Mittelstaedt CA. General ultrasound. 1st ed. New York: Churchill Livingstone;1992. p. 185.
15. Staiano AE, Katzmarzyk PT. Ethnic and sex differences in body fat and visceral and subcutaneous adiposity in children and adolescents. Int J Obes (Lond). 2012; 36:1261–1269.
Article
16. McCrindle BW. Hyperlipidemia in children. Thromb Res. 2006; 118:49–58.
Article
17. Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology. 2007; 132:2191–2207.
Article
18. Boyraz M, Hatipoğlu N, Sarı E, Akçay A, Taşkın N, Ulucan K, et al. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria. Obes Res Clin Pract. 2014; 8:e356–e363.
Article
19. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterol. 2014; 5:277–286.
Article
20. Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014; 28:637–653.
Article
21. Ozturk Y, Soylu OB. Fatty liver in childhood. World J Hepatol. 2014; 6:33–40.
Article
22. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes. 1984; 8:97–106.
23. Holterman AX, Guzman G, Fantuzzi G, Wang H, Aigner K, Browne A, et al. Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. Obesity (Silver Spring). 2013; 21:591–597.
Article
Full Text Links
  • PGHN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr